Amanda Anne Ko

Title: Amanda Anne Ko: Innovator in Fucosidase Inhibitors

Introduction

Amanda Anne Ko is a prominent inventor based in San Rafael, CA (US). She has made significant contributions to the field of biochemistry, particularly in the development of fucosidase inhibitors. With a total of 2 patents to her name, Amanda is recognized for her innovative approaches to treating tumors and cancers.

Latest Patents

Amanda's latest patents focus on fucosidase inhibitors. These compounds are designed to inhibit fucosidase enzymes, which play a crucial role in various biological processes. The patents detail methods and compositions for treating tumors or cancers, including liver disorders and hepatocellular carcinoma. Her work in this area has the potential to impact cancer treatment significantly.

Career Highlights

Amanda is currently associated with Horizon Orphan LLC, where she continues to advance her research and development efforts. Her dedication to innovation in the pharmaceutical field has positioned her as a key figure in her area of expertise.

Collaborations

Throughout her career, Amanda has collaborated with notable colleagues, including Todd C Zankel and Sara Louise Isbell. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Amanda Anne Ko is a trailblazer in the field of fucosidase inhibitors, with a focus on innovative treatments for cancer. Her contributions to the scientific community are invaluable, and her work continues to inspire future advancements in medical research.